Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Merck Sharp & Dohme LLC: 21 Drugs and 116,417 Adverse Event Reports

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Merck Sharp & Dohme LLC manufactures 21 drugs with a combined 116,417 adverse event reports in the FDA FAERS database. Their most reported drug is PEMBROLIZUMAB.

21
Drugs
116,417
Combined Reports
Top Drug
17,770
Total Deaths
42,498
Total Hospitalizations

All Merck Sharp & Dohme LLC Drugs & Safety Profiles

Drug Brand Name Reports Deaths Death Rate Hosp.
PEMBROLIZUMAB KEYTRUDA 83,779 15,543 18.6% 35,472
SUVOREXANT BELSOMRA 9,413 219 2.3% 572
MOLNUPIRAVIR LAGEVRIO 4,788 424 8.9% 802
ERTAPENEM INVANZ 4,069 223 5.5% 1,617
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN VARIVAX 2,002 79 3.9% 265
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN TICE BCG 1,937 69 3.6% 353
SOTATERCEPT-CSRK WINREVAIR 1,585 49 3.1% 596
FIDAXOMICIN Dificid 1,491 181 12.1% 410
LETERMOVIR PREVYMIS 1,416 252 17.8% 398
VORINOSTAT ZOLINZA 1,246 239 19.2% 490
BELZUTIFAN WELIREG 1,021 82 8.0% 550
VERICIGUAT VERQUVO 967 164 17.0% 245
TEDIZOLID SIVEXTRO 769 68 8.8% 217
ERTUGLIFLOZIN PIDOLATE STEGLATRO 681 4 0.6% 128
DORAVIRINE PIFELTRO 442 50 11.3% 94
ELBASVIR ZEPATIER 367 58 15.8% 175
BEZLOTOXUMAB ZINPLAVA 310 59 19.0% 88
HEPATITIS A VIRUS STRAIN 326F ANTIGEN VAQTA 46 2 4.3% 11
CEFTOLOZANE ZERBAXA 37 4 10.8% 14
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN PedvaxHIB 27 1 3.7% 1
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN RECOMBIVAX HB 24 0 N/A 0